Two Sigma Investments, LP Metacrine, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.36 - $0.63 $8,292 - $14,512
-23,035 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.43 - $0.7 $9,905 - $16,124
23,035 New
23,035 $14,000
Q4 2021

Feb 14, 2022
SELL
$0.64 - $3.83 $79,141 - $473,613
-123,659 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.61 - $3.84 $153,561 - $225,930
58,836 Added 90.76%
123,659 $424,000
Q2 2021

Aug 16, 2021
BUY
$3.37 - $5.73 $218,453 - $371,435
64,823 New
64,823 $246,000

Others Institutions Holding MTCR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Metacrine, Inc.

MTCR Quotes by TradingView
  • Ticker MTCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,569,500
  • Description
  • Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
More about MTCR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email